Home | About CDC | Press Room | Funding | A-Z Index | Centers, Institute & Offices | Training & Employment | Contact Us
CDC Centers for Disease Control and Prevention Home Page
_
_  
Search: 
 
_
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
_
Severe Acute Respiratory Syndrome (SARS)

Public Health Guidance for Community-Level Preparedness and Response to Severe Acute Respiratory Syndrome (SARS) Version 2

Supplement B: SARS Surveillance

Summary
May 3, 2005

Download PDF version formatted for print Adobe Acrobat Reader (60 KB/ 2 pages)
Download Word version formatted for print Microsoft Word (350 KB/ 2 pages)

Goals

  • Maximize early detection of cases and clusters of respiratory infections that might signal the re-emergence of SARS-CoV disease while minimizing unnecessary laboratory testing, concerns about SARS-CoV, implementation of control measures, and social disruption.
  • If SARS-CoV transmission recurs, maintain prompt and complete identification and reporting of potential cases to facilitate outbreak control and management.
  • Identify and monitor contacts of cases of SARS-CoV disease to enable early detection of illness in persons at greatest risk.

Key concepts

  • The early clinical features of SARS-CoV disease are not specific enough to reliably distinguish it from other respiratory illnesses.
  • Risk of exposure is key to considering the likelihood of a diagnosis of SARS-CoV disease.
  • Most patients with SARS-CoV disease have a clear history of exposure to another SARS patient or to a setting where SARS-CoV transmission is occurring.
  • SARS-CoV transmission is usually localized and often limited to healthcare settings or households.
  • A cluster of atypical pneumonia in healthcare workers may indicate undetected
  • SARS-CoV transmission.
  • In a setting of extensive SARS-CoV transmission, the possibility of SARS-CoV disease should be considered in all persons with a fever or lower respiratory illness, even if an epidemiologic link cannot be readily established.
  • Up-to-date information on the transmission of SARS-CoV globally is needed to accurately assess exposure risks.
  • Contact tracing is resource intensive yet critical to containment efforts as it allows early recognition of illness in persons at greatest risk.
  • Frequent communication among public health officials and healthcare providers, real-time analysis of data, and timely dissemination of information are essential for outbreak management.
  • Swift action to contain disease should be initiated when a potential case is recognized, even though information sufficient to determine case status may be lacking.

Priority activities

  • Educate clinicians and public health workers on features that can assist in early recognition of SARS and on guidelines for reporting SARS-CoV cases.
  • Develop tools to identify, evaluate, and monitor contacts of SARS-CoV patients.
  • Establish an efficient data management system that links clinical, epidemiologic and laboratory data on cases of SARS-CoV disease and allows rapid sharing of information.
  • Identify surge capacity for investigation of cases and identification, evaluation, and monitoring of contacts in the event of a large SARS outbreak.

 

 

 

_
_
Topic Contents
_ arrow SARS Home
  arrow Community Containment
  arrow Evaluation/Diagnosis
  arrow Exposure Management
  arrow Infection Control
  arrow Laboratory
  arrow Legal Authorities
  arrow Preparedness Planning
  arrow References & Resources
  arrow Surveillance & Reporting
  arrow Travel
  arrow What Everyone Should Know
  arrow What's New
_
_
blackdots
_

Contact Info

Public:
English 800-CDC-INFO
Español 888-246-2857
TTY 888-232-6348
Clinician:
English 877-554-4625
_
arrow Sign up for the Clinician Registry
arrow Contact Us
_
blackdots
_
    Home   |   Policies and Regulations   |   Disclaimer   |   e-Government   |  FOIA   |  Contact Us  
Safer, Healthier People USAGovDHHS Department of Health
and Human Services
Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (800) CDC-INFO